Navigation Links
Significant US Peripheral Nerve Repair Market Opportunity Highlighted in New Independent Research
Date:9/20/2013

Alachua,FL (PRWEB) September 20, 2013

AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the commercialization of technologies for peripheral nerve reconstruction, protection and regeneration, today announced the publication of a new independent research report by Magellan Medical Technology Consultants, Inc. (“MMTC”) on the US peripheral nerve repair market.

The report, which involved primary research via an online survey of nerve repair surgeons plus analysis of publicly available emergency room data and reimbursement data, determined the current size of the peripheral nerve injury repair device market for transected nerves in the United States to be between $1.32 and $1.93 billion per year, with an average of about $1.68 billion per year.

The report provides insight into the importance of transected nerve gap length, noting that each millimeter of nerve gap separation represents greater repair challenges and more complicated treatment decisions. It also emphasizes that there are different approaches to treating transected nerves of varying gap lengths. Researchers examined the distribution of transected gap lengths defined by the surgeons in relation to the surgeons’ decision making process for repair approach to develop a three tiered gap-length treatment model: No/Short Gap (0 –9 mm), Small Gap (9 – 20 mm) and Long Gap (greater than 20 mm).

Jill Schiaparelli, Senior Vice President of Business Strategy & Marketing at AxoGen said, “AxoGen is delighted to see independent validation of the sizable nerve repair market in the United States. Based on the conclusions of this report for the transected nerve repair market, combined with our data on the wrapping and OMF markets, the total current peripheral nerve repair market would be approximately $2.4 billion in the US. We are excited that we are participating in a market with such large opportunity and able to provide new
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Miraca Life Sciences Announces Significant American College of Gastroenterology Tradeshow Plans
2. Dr. Roger Reeves, 2012 Sisley-Jérôme Lejeune Prize Winner, Significantly Advances Understanding of the Biology of Down Syndrome Leading to New Avenues of Research
3. Massage Combined with Resistance Significantly Improves Hamstring Flexibility
4. Oral nutritional supplements demonstrate significant health and cost benefits
5. Figurella Announces Significant Increases in Summer Sales
6. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
7. UC Davis Children's Hospital Study Finds Telemedicine Consultations Significantly Improve Pediatric Care in Rural Emergency Rooms
8. Integrative medicine interventions found to significantly reduce pain, improve quality of life
9. InControl Medical LLC Announces Significant Second Quarter Sales Increase
10. Age-related smelling loss significantly worse in African-Americans
11. Brodalumab demonstrates significant clinical response in psoriatic arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... It is said that nothing makes a lady ... famous wedding dress supplier, shows its new selection of ... promotion. , UWDress.com’s navy cocktail gowns are the cornerstones ... high fashion styles. Simple dresses in bright neon colors can ... are specially designed for those who want to shine among ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... CAGR of 7.2% to reach $5,756.0 million by ... the microscopy market. The electron microscopes product segment ... the forecast period. , Rising focus on nanotechnology, ... growth of the microscopy market. , Get Full ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... be further explored, researchers say , TUESDAY, Nov. 17 ... likely to die after admission to the hospital with ... suggests. , "After admission to a hospital, trauma ... the study authors wrote. "This concerning finding warrants more ...
... show need for improvement , TUESDAY, Nov. 17 (HealthDay ... job of reducing preterm births, according to a new ... high numbers of early, life-threatening deliveries. , , Vermont ... preterm birth rate under 10 percent, while in Louisiana, ...
... BEACH, Calif., Nov. 17 With these tough economic times, ... gifting this year. Imagine being able to donate to ... and overworked feet. Yoga Sandals® Footwear by Beech Sandal ... feet flexible with 20% of each purchase donated to a ...
... ... working is emerging as the top business objective for employer-sponsored wellness programs around the ... New ... is emerging as the top business objective for employer-sponsored wellness programs around ...
... XOWii is continuing ... was launched in early October, has met with much success. XOWii Thin is looking to ... healthy weight control. , ... November 16, 2009 --The XOWii company has made it their vision to be at the ...
... ... a total settlement of $3.25 million for two sanitation workers whose garbage truck was hit by ... Barnes lawyer Michael Cooper. , ... (Lexis Nexis) November 17, 2009 -- New York law firm Cellino & Barnes ...
Cached Medicine News:Health News:Uninsured Trauma Patients More Likely to Die: Study 2Health News:U.S. Scores a 'D' on Preterm Birth Report Card 2Health News:U.S. Scores a 'D' on Preterm Birth Report Card 3Health News:U.S. Scores a 'D' on Preterm Birth Report Card 4Health News:Give a Gift that Gives Back With Yoga Sandals(R) Comfys 2Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 2Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 3Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 4Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 5Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 6Health News:XOWii Launches Second Product in its Line of What are Proving to be Impeccably Designed and Unique Products 2Health News:New York Personal Injury Law Firm Cellino & Barnes Wins $3.25 Million Settlement For Workers Injured in Truck Accident 2
(Date:12/24/2014)...  Actavis plc (NYSE: ACT ) ... complete response letter from the U.S. Food and ... (NDA) for the fixed-dose combination (FDC) of nebivolol ... Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... of a complete response letter, Actavis remains committed ...
(Date:12/24/2014)... 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese ... (API) released unaudited preliminary financial results for the ... Fiscal Year 2015 Ended September 30, 2014 Financial ... with $14.7 million in 1Q14 with gross margins ...
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... from a Phase III,clinical trial evaluating the efficacy ... the treatment of postmenopausal osteoporosis were,presented at the ... Annual Meeting. In the non-inferiority study comparing risedronate ... [Actonel(R) (risedronate sodium,tablets)] increases in bone mineral density ...
... Medical,Technologies, Inc. (Nasdaq: RMTI ), a ... specialty pharmaceuticals focused on the end-,stage-renal-disease market ... in its Phase IIb dose-ranging study for ... drug. The Phase IIb dose-ranging study ...
Cached Medicine Technology:New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 2New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 3New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 4New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 5New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 6Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 2Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 3Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 4
... Releasing the power of clinical information. ... newest generation of clinical connectivity solutions that ... provide effective, high-quality patient care. You will ... be able to share it with your ...
... tool for Clinical Professionals and Researchers., ,S/5 ... easy and efficient way to collect data from ... to days at selectable time intervals. With S/5 ... from the monitor via an interface cable or ...
... Flexible monitoring for intermediate care., ,The ... GE Healthcare Datex-Ohmeda S/5 product line., ,The ... you the power to grow. The new Patient ... hemodynamic measurements up to 12-lead ECG, NIBP, ...
... ,The Datex-Ohmeda S/5 Light Monitor is a ... and critical care areas, in emergency or medium-care ... part of the Datex-Ohmeda S/5 family, the S/5 ... and design shared by all S/5 monitoring products ...
Medicine Products: